Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
[144] ABBOTT LABORATORIES SEC Filing
This article reports on an SEC Form 144 filing by Abbott Laboratories (ABT). The filing indicates a neutral impact and sentiment, detailing a proposed sale of 1144 shares of common stock with an aggregate market value of 132223 USD. The shares were acquired on February 27, 2026, as a vested Restricted Stock Award from the Issuer and are expected to be sold on March 2, 2026, via UBS Financial Services, Inc.